{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:36:18Z","timestamp":1790040978797,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ygeno.2023.110614","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:10:11Z","timestamp":1678885811000},"page":"110614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["SMG7-AS1 as a prognostic biomarker and predictor of immunotherapy responses for skin cutaneous melanoma"],"prefix":"10.1016","volume":"115","author":[{"given":"Xuezheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bairong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0005","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-021-21457-0","article-title":"Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis","volume":"12","author":"Song","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma","volume":"100","author":"Carr","year":"2020","journal-title":"Surg. Clin. North Am."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0015","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","article-title":"Pre-clinical modeling of cutaneous melanoma","volume":"11","author":"Rebecca","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110614_bb0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2105\/AJPH.2020.305567","article-title":"New systematic therapies and trends in cutaneous melanoma deaths among us whites, 1986-2016","volume":"110","author":"Berk-Krauss","year":"2020","journal-title":"Am. J. Public Health"},{"issue":"9","key":"10.1016\/j.ygeno.2023.110614_bb0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-pathol-052016-100208","article-title":"Signaling and immune regulation in melanoma development and responses to therapy","volume":"12","author":"Lin","year":"2017","journal-title":"Ann. Rev. Pathol. Mechan. Disease"},{"issue":"34","key":"10.1016\/j.ygeno.2023.110614_bb0035","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","article-title":"Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody Pembrolizumab in melanoma","volume":"34","author":"Daud","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40425-018-0344-8","article-title":"Predicting response to checkpoint inhibitors in melanoma beyond Pd-L1 and mutational burden","volume":"6","author":"Morrison","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.ygeno.2023.110614_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02648725.2018.1471566","article-title":"Long noncoding Rnas: regulation, function and cancer","volume":"34","author":"Rafiee","year":"2018","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"19","key":"10.1016\/j.ygeno.2023.110614_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194848","article-title":"The functional role of long non-coding Rnas in Melanoma","volume":"13","author":"Wozniak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygeno.2023.110614_bb0055","first-page":"667","article-title":"Identification and validation of immune-related Lncrna signature as a prognostic model for skin cutaneous melanoma","volume":"14","author":"Ping","year":"2021","journal-title":"Pharmgenom. Pers. Med."},{"issue":"2","key":"10.1016\/j.ygeno.2023.110614_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/2211-5463.12030","article-title":"Clinical significance of long noncoding Rna Spry4-It1 in melanoma patients","volume":"6","author":"Liu","year":"2016","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.ygeno.2023.110614_bb0065","doi-asserted-by":"crossref","first-page":"818178","DOI":"10.3389\/fonc.2021.818178","article-title":"Long non-coding Rna Cd27-As1-208 facilitates melanoma progression by activating Stat3 pathway","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ygeno.2023.110614_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding Rnas in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygeno.2023.110614_bb0075","doi-asserted-by":"crossref","first-page":"550987","DOI":"10.3389\/fonc.2020.550987","article-title":"Long noncoding Rnas, new critical regulators in cancer immunity","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygeno.2023.110614_bb0080","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.2147\/IJGM.S335266","article-title":"Using immune-related Lncrna signature for prognosis and response to immunotherapy in cutaneous melanoma","volume":"14","author":"Xue","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110614_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010770","article-title":"Integrative genome comparison of primary and metastatic melanomas","volume":"5","author":"Kabbarah","year":"2010","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ygeno.2023.110614_bb0090","first-page":"1846","article-title":"Geoquery: a bridge between the gene expression omnibus (Geo) and bioconductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinform. (Oxford, England)"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.18632\/oncotarget.13666","article-title":"Mapping heterogeneity in patient-derived melanoma cultures by single-cell Rna-Seq","volume":"8","author":"Gerber","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ygeno.2023.110614_bb0100","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ygeno.2023.110614_bb0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting Cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"W1","key":"10.1016\/j.ygeno.2023.110614_bb0110","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"Gepia: a web server for Cancer and Normal Gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"269","key":"10.1016\/j.ygeno.2023.110614_bb0115","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex Cancer genomics and clinical profiles using the Cbioportal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"D1","key":"10.1016\/j.ygeno.2023.110614_bb0120","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"Panther version 14: more genomes, a new panther go-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ygeno.2023.110614_bb0125","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The Gene ontology resource: enriching a gold mine","volume":"49","author":"Gene Ontology C","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pro.4172","article-title":"Kegg mapping tools for uncovering hidden features in biological data","volume":"31","author":"Kanehisa","year":"2022","journal-title":"Protein Sci. Publ. Protein Soc."},{"issue":"20","key":"10.1016\/j.ygeno.2023.110614_bb0135","first-page":"4200","article-title":"Tisidb: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinform. (Oxford, England)"},{"key":"10.1016\/j.ygeno.2023.110614_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fcell.2020.00629","article-title":"A novel ten-gene signature predicting prognosis in hepatocellular carcinoma","volume":"8","author":"Zhou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/15384047.2022.2054257","article-title":"The Nf-Kappab\/Mir-488\/Erbb2 Axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling","volume":"23","author":"Han","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"10.1016\/j.ygeno.2023.110614_bb0155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with Ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-10-66","article-title":"Health related quality of life outcomes for Unresectable stage iii or iv melanoma patients receiving Ipilimumab treatment","volume":"10","author":"Revicki","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"issue":"2","key":"10.1016\/j.ygeno.2023.110614_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ygeno.2023.110614_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12935-019-0799-9","article-title":"Long non-coding Rna Linc01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt\/Beta-catenin signaling pathway by down-regulating Klk4","volume":"19","author":"Tang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ygeno.2023.110614_bb0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.biopha.2018.01.013","article-title":"Comprehensive analysis and experimental verification of Linc01314 as a tumor suppressor in Hepatoblastoma","volume":"98","author":"Lv","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"37","key":"10.1016\/j.ygeno.2023.110614_bb0180","doi-asserted-by":"crossref","first-page":"61282","DOI":"10.18632\/oncotarget.18058","article-title":"Clinical roles of the aberrantly expressed lncrnas in lung squamous cell carcinoma: a study based on rna-sequencing and microarray data mining","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ygeno.2023.110614_bb0185","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2020.09.035","article-title":"Chromatin interactions in differentiating keratinocytes reveal novel atopic dermatitis- and psoriasis-associated genes","volume":"147","author":"Sahlen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110614_bb0190","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.burns.2019.11.016","article-title":"Expression changes in protein-coding genes and long non-coding Rnas in denatured dermis following thermal injury","volume":"46","author":"Yu","year":"2020","journal-title":"Burns"},{"key":"10.1016\/j.ygeno.2023.110614_bb0195","series-title":"Smg-7 is Required for Mrna Surveillance in Caenorhabditis Elegans.Pdf","year":"2023"},{"issue":"4","key":"10.1016\/j.ygeno.2023.110614_bb0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.molcel.2004.10.013","article-title":"Smg7 acts as a molecular link between Mrna surveillance and Mrna decay","volume":"16","author":"Unterholzner","year":"2004","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.42","article-title":"Smg7 is a critical regulator of P53 stability and function in DNA damage stress response","volume":"2","author":"Luo","year":"2016","journal-title":"Cell Discov."},{"key":"10.1016\/j.ygeno.2023.110614_bb0210","first-page":"81","article-title":"P53 and human cancer: the first ten thousand mutations","author":"Hainaut","year":"1999","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12253-016-0141-y","article-title":"Frameshift mutations of Smg7 essential for nonsense-mediated Mrna decay in gastric and colorectal cancers","volume":"23","author":"Jo","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ygeno.2023.110614_bb0220","doi-asserted-by":"crossref","first-page":"114285","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A nine-Lncrna signature predicts distant relapse-free survival of Her2-negative breast Cancer patients receiving Taxane and anthracycline-based neoadjuvant chemotherapy","volume":"189","author":"Sun","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2013.07.038","article-title":"Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma","volume":"340","author":"Wu","year":"2013","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110614_bb0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pcmr.12371","article-title":"Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma","volume":"28","author":"Ladanyi","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"issue":"6383","key":"10.1016\/j.ygeno.2023.110614_bb0235","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1126\/science.aat2184","article-title":"Natural killers join the fight against cancer","volume":"359","author":"Cerwenka","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110614_bb0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13073-019-0647-5","article-title":"Prognostic value of B cells in cutaneous melanoma","volume":"11","author":"Selitsky","year":"2019","journal-title":"Genome Med."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754323000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754323000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:39:12Z","timestamp":1760164752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754323000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0888754323000587"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2023.110614","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMG7-AS1 as a prognostic biomarker and predictor of immunotherapy responses for skin cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2023.110614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110614"}}